Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

Share Price is delayed by 15 minutes
Get Live Data
537.50    -3.50 (-0.65%)
Bid:
532.50
Ask:
533.50
Spread: 1.00 (0.188%)
Market Cap: £1.45b
CHG Live PriceLast checked at - London Stock Exchange

Intraday Chemring Share Chart

Director/PDMR Shareholding

2 Oct 2020 10:36

RNS Number : 9544A
Chemring Group PLC
02 October 2020
 

2 October 2020

 

Chemring Group PLC

 

Exercise of sharesave options and sale of shares

 

 

Chemring Group PLC ("Chemring" or "the Company") announces that on 1 October 2020 Andrew Lewis and Sarah Ellard, directors of the Company, exercised options granted under the Chemring Group 2008 UK Sharesave Plan on 27 July 2017 and today sold shares as detailed below.

 

The following table details the transactions which were notified to the Company:

 

Director

Options exercised

Number of shares sold

Resultant beneficial interest in the Company's shares

Andrew Lewis

12,162

12,162

113,797

Sarah Ellard

7,297

5,000

107,700

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

 Andrew Lewis

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director/PDMR

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Chemring Group PLC

b)

 

LEI

 

 

213800U9A54VQJ5P2J41

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

1p ordinary shares

 

 

 

GB00B45C9X44

b)

 

Nature of the transaction

 

 

Exercise of options granted on 27 July 2017

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

148p exercise price

 

12,162

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

N/A

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

1 October 2020

f)

 

Place of the transaction

 

 

UK

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

 Andrew Lewis

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director/PDMR

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Chemring Group PLC

b)

 

LEI

 

 

213800U9A54VQJ5P2J41

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

1p ordinary shares

 

 

 

GB00B45C9X44

b)

 

Nature of the transaction

 

 

Sale of shares following exercise of options

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

233p

 

12,162

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

N/A

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

2 October 2020

f)

 

Place of the transaction

 

 

UK

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

 Sarah Ellard

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director/PDMR

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Chemring Group PLC

b)

 

LEI

 

 

213800U9A54VQJ5P2J41

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

1p ordinary shares

 

 

 

GB00B45C9X44

b)

 

Nature of the transaction

 

 

Exercise of options granted on 27 July 2017

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

148p exercise price

 

7,297

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

N/A

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

1 October 2020

f)

 

Place of the transaction

 

 

UK

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

 Sarah Ellard

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director/PDMR

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Chemring Group PLC

b)

 

LEI

 

 

213800U9A54VQJ5P2J41

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

1p ordinary shares

 

 

 

GB00B45C9X44

b)

 

Nature of the transaction

 

 

Sale of shares following exercise of options

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

233p

 

5,000

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

N/A

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

2 October 2020

f)

 

Place of the transaction

 

 

UK

 

 

 

 

For further information:

Chemring Group PLC

 

Sarah Ellard

Group Legal Director

+44 (0)1794 833 901

   

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFIFVAISLFIII
Date   Source Headline
18th Dec 20241:30 pmRNSDirector/PDMR Shareholding
18th Dec 20241:30 pmRNSDirector/PDMR Shareholding
18th Dec 20241:30 pmRNSDirector/PDMR Shareholding
18th Dec 20241:30 pmRNSDirector/PDMR Shareholding
18th Dec 20241:30 pmRNSDirector/PDMR Shareholding
18th Dec 202410:30 amRNSDirector/PDMR Shareholding
18th Dec 202410:30 amRNSDirector/PDMR Shareholding
18th Dec 202410:30 amRNSDirector/PDMR Shareholding
18th Dec 202410:30 amRNSDirector/PDMR Shareholding
18th Dec 202410:30 amRNSDirector/PDMR Shareholding
18th Dec 202410:30 amRNSDirector/PDMR Shareholding
18th Dec 20247:00 amRNSBlock listing Interim Review
17th Dec 202412:49 pmRNSDirector/PDMR Shareholding
17th Dec 20247:00 amRNSResults for the year ended 31 October 2024
5th Dec 20247:00 amRNSDirectorate Change
2nd Dec 20247:00 amRNSTotal Voting Rights
14th Nov 20247:19 amRNSDirector Declaration
6th Nov 20247:15 amRNSDirector Declaration
4th Nov 20247:00 amRNS£278m Contract Wins
1st Nov 20247:00 amRNSTransaction in Own Shares
1st Nov 20247:00 amRNSTotal Voting Rights
31st Oct 20247:00 amRNSTransaction in Own Shares
17th Oct 20247:00 amRNSTrading Update
14th Oct 202412:29 pmRNSHolding(s) in Company
1st Oct 20247:00 amRNSTotal Voting Rights
2nd Sep 20247:00 amRNSTotal Voting Rights
16th Aug 202410:10 amRNSAdditional Listing
5th Aug 202410:03 amRNSDirector/PDMR Shareholding
1st Aug 20247:00 amRNSTotal Voting Rights
18th Jul 20242:34 pmRNSDirector Declaration
1st Jul 20247:00 amRNSTotal Voting Rights
24th Jun 20247:00 amRNSAppointment of Chairman-designate
19th Jun 20247:00 amRNSBlock listing update
18th Jun 20247:00 amRNSBlock listing Interim Review
10th Jun 20247:00 amRNSContract Award
4th Jun 20247:00 amRNSHalf-year Report
3rd Jun 20247:00 amRNSTotal Voting Rights
1st May 202411:29 amRNSTotal Voting Rights
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20249:13 amRNSTotal Voting Rights
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSDirector/PDMR Shareholding
25th Mar 20247:00 amRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSFunding Awards
18th Mar 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.